‘AV Magni-Visualiser’ Screening Device for Cervical Cancer ...
The device has been designed and developed at Institute of Cytology and Preventive Oncology (ICPO), NOIDA which is one of the premier Institutes of ICMR and is involved in epidemiology and development of indigenous HPV vaccine.
Cervical cancer is still the number one killer cancer in several parts of rural and semi-urban India. It has been estimated that about 1 lakh 32 thousand cases of cervical cancer are diagnosed every year and 74, 000 deaths occur due to it every year. It accounted for 9% of total deaths due to cancer in 2010.
With this device it will be easy to screen and detect cervical cancer in its early stages thus making treatment more effective.This device, which will be much cost effective, will be first rolled out in the district and sub-district community health centres (CMCs) and subsequently in the primary health centres (PHCs).As not all PHCs have lady doctors and nurses, staffing and training will form an important part of roll out paln.
Cervical cancer does not occur de-novo. It starts from certain pre-cancerous states/lesions called dysplasias and it takes about a decade for cancer to develop from pre-cancerous lesions. Detection and appropriate treatment of pre-cancerous lesions will halt their progression to invasive cancers.
This device has a white light source with variable interchangeable magnification and it can be operated on 12 Volt battery in rural and semi urban areas where electric supply is not regular. Magnivisualizer has been found to pick up 1.5 times more High grade pre-cancerous and cancerous lesions than the ordinary tungsten light.
No comments:
Post a Comment